157 related articles for article (PubMed ID: 38147021)
1. Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.
Xu S; Liu D; Qin Z; Liang Z; Xie H; Yi B; Wang K; Lin G; Liu R; Yang K; Xu Y; Zhang H
Aging (Albany NY); 2023 Dec; 15(24):15134-15160. PubMed ID: 38147021
[TBL] [Abstract][Full Text] [Related]
2.
Wang C; Wang J; Chen S; Li K; Wan S; Yang L
Curr Cancer Drug Targets; 2024; 24(3):340-353. PubMed ID: 37592784
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
Liu Q; Zhao H; Guo Y; Zhang K; Shang F; Liu T
J Healthc Eng; 2022; 2022():7904982. PubMed ID: 36105715
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
6. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.
Wang B; Zhong JL; Li HZ; Wu B; Sun DF; Jiang N; Shang J; Chen YF; Xu XH; Lu HD
Life Sci; 2021 Jul; 277():119452. PubMed ID: 33831430
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
9. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
10. High expression COL10A1 promotes breast cancer progression and predicts poor prognosis.
Zhou W; Li Y; Gu D; Xu J; Wang R; Wang H; Liu C
Heliyon; 2022 Oct; 8(10):e11083. PubMed ID: 36281404
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
[TBL] [Abstract][Full Text] [Related]
12. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of
Liu J; Zhu B; Chen J; Cao Y
Anticancer Res; 2023 Oct; 43(10):4491-4509. PubMed ID: 37772558
[TBL] [Abstract][Full Text] [Related]
14. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
Cheng X; Zeng Z; Yang H; Chen Y; Liu Y; Zhou X; Zhang C; Wang G
BMC Cancer; 2023 Jan; 23(1):105. PubMed ID: 36717792
[TBL] [Abstract][Full Text] [Related]
15. Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker.
Li J; Hou H; Sun J; Ding Z; Xu Y; Li G
Funct Integr Genomics; 2023 Mar; 23(2):105. PubMed ID: 36977915
[TBL] [Abstract][Full Text] [Related]
16. MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen α-1(X) chain gene.
Guo Q; Zheng M; Xu Y; Wang N; Zhao W
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30442874
[TBL] [Abstract][Full Text] [Related]
17. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13.
Zhang H; Yin H; Chen J; Yuan Y
Front Oncol; 2022; 12():791962. PubMed ID: 35141160
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy.
Xu C; Li F; Liu Z; Yan C; Xiao J
BMC Med Genomics; 2023 Feb; 16(1):34. PubMed ID: 36829159
[TBL] [Abstract][Full Text] [Related]
20. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
